ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd
Your view on ECS.AX
Overview
What the company does, where it operates, and who runs it.
About ECS Botanics Holdings Ltd
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nan-Maree Schoerie Chem
- Headquarters
- 94 Green Rises Road, Launceston, TAS, AU
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nan-Maree Schoerie Chem
- Headquarters
- 94 Green Rises Road, Launceston, TAS, AU
ECS Botanics Holdings Ltd specializes in the cultivation, processing, and commercialization of medicinal cannabis products. The enterprise also markets a variety of hemp-derived wellness and food items and is active in the agricultural sector. Its primary operations are headquartered in Launceston, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for ECS Botanics Holdings Ltd. Starting points for ECS Botanics Holdings Ltd: beta 1.60 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for ECS Botanics Holdings Ltd. ECS Botanics Holdings Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for ECS Botanics Holdings Ltd. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2011 | This yearYear to Jun 2001 | Next yearYear to Jun 2011 |
|---|---|---|---|
| Average estimate | AUD 0.00 | −AUD 4,413.70 | AUD 0.00 |
| Lowest estimate | AUD 0.00 | −AUD 4,588.50 | AUD 0.00 |
| Highest estimate | AUD 0.00 | −AUD 4,282.60 | AUD 0.00 |
| Number of analysts | 0 | 2 | 0 |
| A year ago | — | — | — |
| Growth vs a year ago | — | — | — |
Revenue estimates
| Total | This quarterSep 2011 | This yearYear to Jun 2001 | Next yearYear to Jun 2011 |
|---|---|---|---|
| Average estimate | AUD 72.00M | AUD 3.68M | AUD 72.00M |
| Lowest estimate | AUD 72.00M | AUD 3.52M | AUD 72.00M |
| Highest estimate | AUD 72.00M | AUD 3.70M | AUD 72.00M |
| Number of analysts | 1 | 2 | 1 |
| A year ago | — | — | — |
| Growth vs a year ago | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for ECS Botanics Holdings Ltd. ECS Botanics Holdings Ltd has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| CAN.AXCann Group Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| CHM.AXChimeric Therapeutics Limited | Healthcare | Biotechnology | — | ||
| HIQ.AXHITIQ Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| ICR.AXIntelicare Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| IME.AXImExHS Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IVX.AXInvion Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| IXC.AXInvex Therapeutics Ltd | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| SKTOSK3 Group, Inc. | Healthcare | OTC | $1,395 | ||
| SKYISky Century Investment, Inc. | Healthcare | OTC | $223,725 | ||
| SLNXSolanbridge Group, Inc. | Healthcare | OTC | $95,200 | ||
| SMDPYSumitomo Pharma Co., Ltd. | Healthcare | OTC | $6.1B | ||
| SNNVFSunniva Inc. | Healthcare | OTC | $392 | ||
| SNOASonoma Pharmaceuticals, Inc. | Healthcare | NASDAQ | $4.2M | ||
| SNT.AXSyntara Limited | Healthcare | ASX | — | ||
| SPBBFSpeakeasy Cannabis Club Ltd. | Healthcare | OTC | $1,315 | ||
| SPLMSentry Petroleum Ltd | Healthcare | OTC | $4,745 | ||
| SRUTFSproutly Canada Inc. | Healthcare | OTC | $3,130 | ||
| STEKStemtech Corporation | Healthcare | OTC | $55,547 | ||
| STHZFStateHouse Holdings Inc. | Healthcare | OTC | $356,014 | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of ECS Botanics Holdings Ltd.